Ensign Peak Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-34,790
Closed -$584K 2236
2022
Q1
$584K Hold
34,790
﹤0.01% 1483
2021
Q4
$695K Sell
34,790
-53,810
-61% -$1.01M ﹤0.01% 1471
2021
Q3
$1.61M Hold
88,600
﹤0.01% 1234
2021
Q2
$2.39M Hold
88,600
﹤0.01% 1016
2021
Q1
$2.65M Hold
88,600
0.01% 947
2020
Q4
$2.55M Sell
88,600
-100
-0.1% -$2.7K 0.01% 928
2020
Q3
$2.16M Hold
88,700
0.01% 927
2020
Q2
$1.59M Sell
88,700
-47,511
-35% -$624K ﹤0.01% 1091
2020
Q1
$1.11M Buy
136,211
+52,711
+63% +$602K ﹤0.01% 1127
2019
Q4
$1.1M Buy
+83,500
New +$1.01M ﹤0.01% 1296

Other funds holding CVET

Ensign Peak Advisors's CVET Position: Q2 2022 in Review

Ensign Peak Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 34,790 shares — an estimated $584K sold.

Ensign Peak Advisors first reported a position in CVET in Q4 2019 and held it in 10 quarters. The position peaked at $2.65M in Q1 2021. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • Ensign Peak Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 34,790 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $584K.
  • Ensign Peak Advisors first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Ensign Peak Advisors's Covetrus, Inc. Common Stock position peaked at $2.65M in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.